首页> 中文期刊> 《中国医药指南》 >红霉素联合沐舒坦雾化吸入治疗百日咳综合征的临床疗效分析

红霉素联合沐舒坦雾化吸入治疗百日咳综合征的临床疗效分析

             

摘要

目的:观察红霉素联合沐舒坦雾化吸入治疗百日咳综合征的临床疗效。方法将明确诊断为百日咳综合征的86例患儿随机分为2组:治疗组给予红霉素静脉滴注和沐舒坦雾化吸入联合治疗,对照组给予红霉素静脉滴注治疗,比较2组治疗的疗效。结果治疗组的治疗总有效率为93.02%,对照组总有效率为79.07%,2组比较有统计学(P<0.05)。结论红霉素联合沐舒坦雾化吸入治疗百日咳综合征有良好的疗效。%Objective To observe the clinical effect of erythromycin and ambroxol atomization inhaled in treating pertussis syndrome. Methods A total of 86 patients with pertussis syndrome were divided randomly into the treatment group (erythromycin iv. drip, ambroxol atomization inhaled) and the control group (erythromycin iv.drip). Results The total effective of the treatment group was better than the control group (93.02%, 79.07%, P<0.05); the treatment group can improve the symptoms of patients (P<0.05). Conclusion The methods of erythromycin and ambroxol atomization inhaled in treating pertussis syndrome has a good effect in the treatment of pertussis syndrome.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号